Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesParkinsons disease, levodopa-use and the risk of melanoma
Parkinsonism & Related Disorders, 08/21/09
Vermeij JD et al. – The factors responsible for increased development of melanomas in Parkinsons disease (PD) pts are unknown; this association needs further study. Based on these findings, authors recommend removal of the associated drug insert warning for levodopa as it may cause unnecessary fear for pts and physician resistance to prescribing this drug.
Methods- Opinion on Parkinsons disease, levodopa use, and melanoma risk
- Literature since 1970s suggests association between PD with levodopa use and increased risk for malignant melanoma
- Possible association noted on drug insert for levodopa
- Findings based on 5 studies: 1) risk increased for melanomas in PD pts; 2) increased risk is present before PD diagnosis; 3) a role for levodopa is unlikely
Related Articles
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Cochrane Reviews, 10/09/09
Relevance Score: 81%
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
The Lancet Neurology, 11/18/09
Relevance Score: 79%
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Brain, 10/30/09
Relevance Score: 70%
Widely Used Cholesterol-lowering Drug May Prevent Progression Of Parkinsons Disease
ScienceDaily, 11/10/09
Relevance Score: 69%
Condition Raises Parkinsons Risk 5-Fold
Ivanhoe, 10/27/09
Relevance Score: 69%
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease
Brain, 12/07/09
Cognitive and Neuropsychiatric Profile of the Synucleinopathies: Parkinson Disease, Dementia With Lewy Bodies, and Multiple System Atrophy
Alzheimer Disease & Associated Disorders , 12/07/09
Acupuncture in the treatment of temporo-mandibular disorders in Sydenham's chorea patient: a case report
Acupuncture in Medicine, 12/07/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
European Journal of Cancer, 12/07/09
DO Intracranial Neoplasms Differ in Ollier Disease and Maffucci Syndrome? An in-Depth Analysis of the Literature
Neurosurgery, 12/07/09
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/07/09
Sponsor
Article Search
Sponsor